Find Olopatadine Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF DossiersDRUG PRODUCT COMPOSITIONS

115RELATED EXCIPIENT COMPANIES

206EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 140462-76-6, Olopatadine hcl, Allelock, Pataday, Patanase, Alo4943a
Molecular Formula
C21H24ClNO3
Molecular Weight
373.9  g/mol
InChI Key
HVRLZEKDTUEKQH-NOILCQHBSA-N
FDA UNII
2XG66W44KF

Olopatadine Hydrochloride
An antihistamine with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.
1 2D Structure

Olopatadine Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
2.1.2 InChI
InChI=1S/C21H23NO3.ClH/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;
2.1.3 InChI Key
HVRLZEKDTUEKQH-NOILCQHBSA-N
2.1.4 Canonical SMILES
CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl
2.1.5 Isomeric SMILES
CN(C)CC/C=C\1/C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
2XG66W44KF
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic Acid

2. 4679, Kw

3. Hydrochloride, Olopatadine

4. Kw 4679

5. Kw 4943a

6. Kw-4679

7. Kw-4943a

8. Kw4943a

9. Olopatadine

10. Patanol

2.3.2 Depositor-Supplied Synonyms

1. 140462-76-6

2. Olopatadine Hcl

3. Allelock

4. Pataday

5. Patanase

6. Alo4943a

7. Pazeo

8. Kw4679

9. Kw-4679

10. Olopatadine (hydrochloride)

11. Alo-4943a

12. (z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic Acid Hydrochloride

13. Olopatadine (as Hydrochloride)

14. 2xg66w44kf

15. Dsstox_cid_26486

16. Dsstox_rid_81657

17. Dsstox_gsid_46486

18. Dibenz(b,e)oxepin-2-acetic Acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, Hydrochloride, (z)-

19. Olopine

20. Patadine

21. Olopax

22. Chembl1719

23. Kw 4679

24. Cas-140462-76-6

25. Opatanol (tn)

26. Unii-2xg66w44kf

27. Sr-01000763388

28. Alo 4943a

29. Olopatadine Hydrochloride [usan]

30. Allelock (tn)

31. Patanol (tn)

32. De 114

33. Mfcd00875716

34. Olopatadine Hydrochloride [usan:usp]

35. Olopatadine Hydrochlorde

36. O-ppds

37. Ncgc00164623-01

38. Schembl23213

39. Mls001401465

40. Dtxsid0046486

41. Chebi:31933

42. Hy-b0426a

43. Olopatadine Hydrochloride- Bio-x

44. Al4943a

45. Alo4943a;kw4679

46. 2-[(11z)-11-[3-(dimethylamino)propylidene]-6h-benzo[c][1]benzoxepin-2-yl]acetic Acid;hydrochloride

47. Dibenz[b,e]oxepin-2-acetic Acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, Hydrochloride (1:1), (11z)-

48. Ex-a1347

49. Olopatadine Hydrochloride (opatanol)

50. Tox21_112242

51. S2494

52. Olopatadine Hydrochloride [mi]

53. Akos015895232

54. Akos025149118

55. Olopatadine Hydrochloride (jp17/usp)

56. Tox21_112242_1

57. Bcp9001022

58. Ccg-101141

59. H06o056

60. Ks-1228

61. Nc00391

62. Olopatadine Hydrochloride [jan]

63. Ncgc00263532-01

64. Olopatadine Hydrochloride [mart.]

65. Olopatadine Hydrochloride [vandf]

66. 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic Acid Hydrochloride

67. 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic Acid, Hydrochloride

68. Bo164171

69. Dibenz(b,e)oxepin-2-acetic Acid, 11-(3-dimethylamino)propylidene)-6,11-dihydro-, Hydrochloride, (z)-

70. Olopatadine Hydrochloride [usp-rs]

71. Olopatadine Hydrochloride [who-dd]

72. Smr000469220

73. Olopatadine Hydrochloride, >=98% (hplc)

74. Olopatadine Hydrochloride [ema Epar]

75. O0361

76. C72607

77. D01192

78. Olopatadine Hydrochloride [orange Book]

79. Olopatadine Hydrochloride [usp Monograph]

80. A807652

81. Ryaltris Component Olopatadine Hydrochloride

82. Q-201511

83. Sr-01000763388-4

84. Olopatadine Hydrochloride Component Of Ryaltris

85. Q27255766

86. Olopatadine Hydrochloride, United States Pharmacopeia (usp) Reference Standard

87. (z)-11-[3-(dimethylamino)propylidene]-6,11-dihydro-dibenz[b,e]oxepin-2-acetic Acid Hydrochloride

88. (z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)aceticacidhydrochloride

2.4 Create Date
2005-10-11
3 Chemical and Physical Properties
Molecular Weight 373.9 g/mol
Molecular Formula C21H24ClNO3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass373.1444713 g/mol
Monoisotopic Mass373.1444713 g/mol
Topological Polar Surface Area49.8 Ų
Heavy Atom Count26
Formal Charge0
Complexity488
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 8  
Drug NameOlopatadine hydrochloride
Drug LabelOlopatadine Hydrochloride Nasal Solution (Nasal Spray), 665 micrograms (mcg) is a metered-spray solution for intranasal administration. Olopatadine hydrochloride, the active component of Olopatadine Hydrochloride Nasal Solution (Nasal Spray), is a wh...
Active IngredientOlopatadine hydrochloride
Dosage FormSolution/drops; Spray, metered; Solution
RouteOphthalmic; Nasal; ophthalmic
Strength0.665mg/spray; 0.2% base; 0.1%; eq 0.1% base; 0.2%
Market StatusTentative Approval; Prescription
CompanyWockhardt; Apotex; Sandoz; Watson Labs; Barr

2 of 8  
Drug NamePataday
Drug LabelPATADAY (olopatadine hydrochloride ophthalmic solution) 0.2% is a sterile ophthalmic solution containing olopatadine for topical administration to the eyes.Olopatadine hydrochloride is a white, crystalline, water-soluble powder with a molecular we...
Active IngredientOlopatadine hydrochloride
Dosage FormSolution/drops
RouteOphthalmic
Strengtheq 0.2% base
Market StatusPrescription
CompanyAlcon Pharms

3 of 8  
Drug NamePatanase
PubMed HealthOlopatadine (Into the nose)
Drug ClassesNasal Agent
Drug LabelPATANASE (olopatadine hydrochloride) Nasal Spray, 665 micrograms (mcg) is a metered-spray solution for intranasal administration. Olopatadine hydrochloride, the active component of PATANASE Nasal Spray, is a white, water-soluble crystalline powder. T...
Active IngredientOlopatadine hydrochloride
Dosage FormSpray, metered
RouteNasal
Strength0.665mg/spray
Market StatusPrescription
CompanyAlcon Pharms

4 of 8  
Drug NamePatanol
PubMed HealthOlopatadine
Drug ClassesNasal Agent, Ophthalmologic Agent
Drug LabelPATANOL (olopatadine hydrochloride ophthalmic solution) 0.1% is a sterile ophthalmic solution containing olopatadine, a relatively selective H1-receptor antagonist and inhibitor of histamine release from the mast cell for topical administration to...
Active IngredientOlopatadine hydrochloride
Dosage FormSolution/drops
RouteOphthalmic
Strengtheq 0.1% base
Market StatusPrescription
CompanyAlcon

5 of 8  
Drug NameOlopatadine hydrochloride
Drug LabelOlopatadine Hydrochloride Nasal Solution (Nasal Spray), 665 micrograms (mcg) is a metered-spray solution for intranasal administration. Olopatadine hydrochloride, the active component of Olopatadine Hydrochloride Nasal Solution (Nasal Spray), is a wh...
Active IngredientOlopatadine hydrochloride
Dosage FormSolution/drops; Spray, metered; Solution
RouteOphthalmic; Nasal; ophthalmic
Strength0.665mg/spray; 0.2% base; 0.1%; eq 0.1% base; 0.2%
Market StatusTentative Approval; Prescription
CompanyWockhardt; Apotex; Sandoz; Watson Labs; Barr

6 of 8  
Drug NamePataday
Drug LabelPATADAY (olopatadine hydrochloride ophthalmic solution) 0.2% is a sterile ophthalmic solution containing olopatadine for topical administration to the eyes.Olopatadine hydrochloride is a white, crystalline, water-soluble powder with a molecular we...
Active IngredientOlopatadine hydrochloride
Dosage FormSolution/drops
RouteOphthalmic
Strengtheq 0.2% base
Market StatusPrescription
CompanyAlcon Pharms

7 of 8  
Drug NamePatanase
PubMed HealthOlopatadine (Into the nose)
Drug ClassesNasal Agent
Drug LabelPATANASE (olopatadine hydrochloride) Nasal Spray, 665 micrograms (mcg) is a metered-spray solution for intranasal administration. Olopatadine hydrochloride, the active component of PATANASE Nasal Spray, is a white, water-soluble crystalline powder. T...
Active IngredientOlopatadine hydrochloride
Dosage FormSpray, metered
RouteNasal
Strength0.665mg/spray
Market StatusPrescription
CompanyAlcon Pharms

8 of 8  
Drug NamePatanol
PubMed HealthOlopatadine
Drug ClassesNasal Agent, Ophthalmologic Agent
Drug LabelPATANOL (olopatadine hydrochloride ophthalmic solution) 0.1% is a sterile ophthalmic solution containing olopatadine, a relatively selective H1-receptor antagonist and inhibitor of histamine release from the mast cell for topical administration to...
Active IngredientOlopatadine hydrochloride
Dosage FormSolution/drops
RouteOphthalmic
Strengtheq 0.1% base
Market StatusPrescription
CompanyAlcon

4.2 Drug Indication

Treatment of ocular signs and symptoms of seasonal allergic conjunctivitis.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Histamine H1 Antagonists, Non-Sedating

A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)


Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]; Decreased Histamine Release [PE]
5.3 ATC Code

S01GX09


API SUPPLIERS

read-more
read-more

01

Seqens

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF ASMF, BR... arrow-down AUDIT arrow-down
Seqens Company Banner

02

Bhavna Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Bhavna Labs

03

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

04

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

05

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, MX arrow-down AUDIT
HRV Global Life Sciences

06

Tenatra Exports

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Tenatra

07

Zeon Pharma Industries India Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Zeon Pharma Industries India Pvt Ltd

08

Shamrock Pharmachemi

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTogether we can improve the quality of life

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

09

Curia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Company Banner

10

Curia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Pcas

France
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-07

Pay. Date : 2013-01-02

DMF Number : 23908

Submission : 2010-06-18

Status : Active

Type : II

Seqens Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-06-25

Pay. Date : 2012-12-24

DMF Number : 25044

Submission : 2011-06-13

Status : Active

Type : II

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2016-03-02

Pay. Date : 2016-02-12

DMF Number : 19526

Submission : 2006-06-14

Status : Active

Type : II

Company Banner

04

Arvo
Not Confirmed

05

Indoco Remedies Ltd

India

USDMF

arrow
Arvo
Not Confirmed

05

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-06-23

Pay. Date : 2014-06-17

DMF Number : 24106

Submission : 2010-08-27

Status : Active

Type : II

blank

06

Kyowa Kirin Co Ltd

Japan

USDMF

arrow
Arvo
Not Confirmed

07

Medichem Sa

Spain

USDMF

arrow
Arvo
Not Confirmed

07

Medichem Sa

Spain
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-09-23

Pay. Date : 2015-09-14

DMF Number : 22532

Submission : 2009-02-12

Status : Active

Type : II

blank

08

Arvo
Not Confirmed

08

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-05-28

Pay. Date : 2013-12-17

DMF Number : 24624

Submission : 2011-02-08

Status : Active

Type : II

blank

09

Phf Sa

Switzerland

USDMF

arrow
Arvo
Not Confirmed

09

Phf Sa

Switzerland
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 24408

Submission : 2010-12-17

Status : Inactive

Type : II

blank

10

Urquima Sa

Spain

USDMF

arrow
Arvo
Not Confirmed

10

Urquima Sa

Spain
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19417

Submission : 2006-05-09

Status : Inactive

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

Olopatadine Hydrochloride

Registration Number : 305MF10136

Registrant's Address : Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain

Initial Date of Registration : 2023-12-19

Latest Date of Registration : 2023-12-19

Company Banner

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registration Number : 304MF10045

Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Mahara...

Initial Date of Registration : 2022-02-24

Latest Date of Registration : 2022-02-24

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine Hydrochloride (Olopatadine HCl)

Registration Number : 303MF10171

Registrant's Address : No. 69 Xingguang Avenue, Renhe Town, Yubei District, Chongqing, China

Initial Date of Registration : 2021-12-02

Latest Date of Registration : 2021-12-02

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registration Number : 223MF10009

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2011-01-21

Latest Date of Registration : 2023-07-12

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registration Number : 222MF10253

Registrant's Address : 110, MAGOKDONG-RO, GANGSEO-GU, SEOUL, KOREA

Initial Date of Registration : 2010-10-28

Latest Date of Registration : 2010-10-28

blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Japanese Pharmacopoeia Olopatadine Hydrochloride (For Manufacturing Use Only)

Registration Number : 226MF10140

Registrant's Address : 530 Chokeiji, Takaoka City, Toyama Prefecture

Initial Date of Registration : 2014-07-31

Latest Date of Registration : 2016-06-06

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registration Number : 224MF10094

Registrant's Address : Plot No: C-24, Sanath Nagar Industrial Estate, Sanath Nagar, Hyderabad, Telangana, In...

Initial Date of Registration : 2012-04-27

Latest Date of Registration : 2021-06-01

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride (K)

Registration Number : 225MF10202

Registrant's Address : 2-27-1 Shinkawa, Chuo-ku, Tokyo

Initial Date of Registration : 2013-11-11

Latest Date of Registration : 2013-11-11

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registration Number : 222MF10280

Registrant's Address : 2-7-1 Nihonbashi, Chuo-ku, Tokyo

Initial Date of Registration : 2010-12-24

Latest Date of Registration : 2012-05-22

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride USP

Date of Issue : 2025-10-07

Valid Till : 2028-10-06

Written Confirmation Number : WC-0119

Address of the Firm : Plot No. 35, 36, 38, 39, 40, 49, 50 & 51, Phase-IV, IDA, Jeedimetla, Medchal-Mal...

blank

02

FDC

India
AOCS Annual Meeting
Not Confirmed
arrow

FDC

India
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride IH/USP/IP

Date of Issue : 2025-08-08

Valid Till : 2028-07-07

Written Confirmation Number : WC-0055

Address of the Firm : Plot No. 19 & 20/2, MIDC, Dhatav, Taluka: Roha, District-Raigad, Maharashtra, In...

blank

03

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride USP

Date of Issue : 2025-10-24

Valid Till : 2027-10-23

Written Confirmation Number : WC-0625

Address of the Firm : PLOT NO.: В-29/1, MIDC MAHAD, VILLAGE BIRWADI,MAHAD - 402301, Taluka: MAHAD, Di...

blank

04

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride USP

Date of Issue : 2025-08-05

Valid Till : 2028-07-15

Written Confirmation Number : WC-0152

Address of the Firm : Kilo Lab, R-92-93,15 Floor, T.T.C. M.I.D.C., Thane Belapur Road, Navi Mumbai., R...

blank

05

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride IP/JP/USP

Date of Issue : 2022-08-04

Valid Till : 2025-07-22

Written Confirmation Number : WC-0341

Address of the Firm : Plot No. J-46/57, MIDC Taloja Panvel, Raigad-410208, Maharashtra, India

blank

06

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride IH/USP

Date of Issue : 2025-07-07

Valid Till : 2028-07-14

Written Confirmation Number : WC-0021

Address of the Firm : Sy. Nos, 317,320,321,322,323,604 & 605, Pincode-502329, Rudraram (Village), Pata...

blank

07

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride USP

Date of Issue : 2022-07-27

Valid Till : 2025-07-26

Written Confirmation Number : WC-0531

Address of the Firm : Plot No. D-90/3 TTC IND Area, MIDC Turbhe, Navi Mumbai- 400705,Taluka: Pawvane, ...

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine Hydrochloride IH/USP

Date of Issue : 2022-06-08

Valid Till : 2025-07-25

Written Confirmation Number : WC-0159nA2

Address of the Firm : A-7/A-8, M.I.D.C Industrial Area, Ahmednagar-414111, Maharashtra, India

blank

09

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Olopatadine Hydrochloride USP/IH

Date of Issue : 2025-07-14

Valid Till : 2028-02-06

Written Confirmation Number : WC-0012

Address of the Firm : B-1/8,MIDC, Lote Parshuram, Tal., Dist. Ratnagiri, Khed - 415722, Taluka: Khed, ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Curia

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

Olopatadine hydrochloride

Registrant Name : Goodwills Co., Ltd.

Registration Date : 2021-04-28

Registration Number : 20210428-209-J-960

Manufacturer Name : Curia Spain SAU

Manufacturer Address : Parque Tecnológico Boecillo, Parcelas 2y 3, Boecillo, 47151 Valladolid, Spain

Company Banner

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Kolon Life Science Co., Ltd.

Registration Date : 2024-09-11

Registration Number : 20240911-209-J-1704

Manufacturer Name : Aurore Pharmaceuticals Priva...

Manufacturer Address : Plot No. 35, 36, 38 to 40, 49 to 51 Phase IV, IDA, Jeedimetla, Hyderabad Telangana Je...

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Medipoem Co., Ltd.

Registration Date : 2026-04-14

Registration Number : 20251229-209-J-2080(1)

Manufacturer Name : Chongqing Huapont Shengchem ...

Manufacturer Address : No. 6, Huanan 1st Road, Yanjia Avenue, Changshou District, Chongqing 401221, China

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Ace Biopharm Co., Ltd.

Registration Date : 2025-12-29

Registration Number : 20251229-209-J-2080

Manufacturer Name : Chongqing Huapont Shengchem ...

Manufacturer Address : No. 6, Huanan 1st Road, Yanjia Avenue, Changshou District, Chongqing 401221, China

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Ace Biopharm Co., Ltd.

Registration Date : 2021-03-30

Registration Number : 20210330-209-J-913

Manufacturer Name : FIS-Fabbrica Italiana Sintet...

Manufacturer Address : Viale Milano, 26 Alte di Montecchio Maggiore, Vicenza, Italy

blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Next Bio Co., Ltd.

Registration Date : 2026-04-14

Registration Number : 20260414-209-J-2149

Manufacturer Name : Flax Laboratories Private Li...

Manufacturer Address : Plot No. B-29/1, MIDC Mahad, Village-Birwadi, Mahad-402301 Tal-Mahad, Dist-Raigad, Ma...

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Chong Kun Dang Co., Ltd.

Registration Date : 2021-04-22

Registration Number : 20181116-209-J-150(2)

Manufacturer Name : Indoco Remedies Limited (KIL...

Manufacturer Address : R-92/93, 1st floor, TTC, MIDC, Thane Belapur Road, Rabale, Navi Mumbai, Thane 400701....

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Bansen Co., Ltd.

Registration Date : 2022-11-28

Registration Number : 20181116-209-J-150(3)

Manufacturer Name : Indoco Remedies Limited

Manufacturer Address : Kilo Lab, R-92/93, 1st floor TTC MIDC area, Thane-Belapur Road, Rabale, Navi Mumbia 4...

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Novartis Korea

Registration Date : 2021-05-20

Registration Number : 20210503-209-J-967(A)

Manufacturer Name : Kyowa Pharma Chemical Co., L...

Manufacturer Address : 530 Chokeiji, Takaoka, Toyama 933-8511, Japan

blank

10

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Olopatadine hydrochloride

Registrant Name : Korea Kyowa Kirin Co., Ltd.

Registration Date : 2021-05-03

Registration Number : 20210503-209-J-967

Manufacturer Name : Kyowa Pharma Chemical Co., L...

Manufacturer Address : 530 Chokeiji, Takaoka, Toyama 933-8511, Japan

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

PCAS FINLAND

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 51014-7733

Start Marketing Date : 2010-04-26

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Seqens Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 65089-0041

Start Marketing Date : 1996-12-18

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Company Banner

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 73377-336

Start Marketing Date : 2025-10-28

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 52133-0036

Start Marketing Date : 1996-12-18

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 48087-0165

Start Marketing Date : 2023-09-05

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

FDC Limited

India
Arvo
Not Confirmed
arrow

FDC Limited

India
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 55545-0464

Start Marketing Date : 2015-05-02

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 12079-2002

Start Marketing Date : 2013-10-15

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 53296-0078

Start Marketing Date : 2010-05-27

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (75kg/75kg)

Marketing Category : BULK INGREDIENT

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 14501-0050

Start Marketing Date : 2010-03-25

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

OLOPATADINE HYDROCHLORIDE

NDC Package Code : 62756-041

Start Marketing Date : 2025-03-31

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (5kg/5kg)

Marketing Category : BULK INGREDIENT

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Seqens

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

Olopatadine Hydrochloride

About the Company : Founded in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. The company supports customers in the development, scale-up, and man...

Founded in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. The company supports customers in the development, scale-up, and manufacturing of drug substances from pre-clinical to commercial stages. Seqens offers a broad portfolio of APIs and proprietary products, along with custom solutions for healthcare, electronics, and cosmetics. With 15 industrial plants and 5 R&D centers worldwide, Seqens produces complex molecules across small- and large-scale requirements. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Seqens Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Flag India
Digital Content Digital Content

Olopatadine Hydrochloride

About the Company : Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian manufacturer of APIs and intermediates. The company is approved by the FDA of India and holds cGMP certification for it...

Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian manufacturer of APIs and intermediates. The company is approved by the FDA of India and holds cGMP certification for its products, while also complying with WHO GMP standards. Bhavna focuses on muscle relaxants and ophthalmic products and provides custom manufacturing services. Its cGMP-compliant facility near Mumbai has a production capacity exceeding 500 tonnes per year, with exports across Southeast Asia, the Middle East, and Europe. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Bhavna Labs

03

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Olopatadine Hydrochloride

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Olopatadine Hydrochloride

About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...

Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and regulatory support, and strives for global standards. Known for quality and affordability, it has established a niche through innovative methods and exports to nearly every continent. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Jai Radhe Sales

05

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Olopatadine Hydrochloride

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

Flag India
Digital Content Digital Content

Olopatadine Hydrochloride

About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...

Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opportunities grew, it was felt that the proprietorship firm had outlived its usefulness and that it needed a corporate structure. So, Tenatra Exports Private Limited was incorporated in 2002. Since then, the company has come a long way, gaining valuable experience and knowledge in the fields of chemicals and pharmaceuticals in India. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Tenatra

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content

Olopatadine HCl

About the Company : Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herba...

Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herbal extracts, semi-finished granules, and finished formulations such as tablets, capsules, and dry suspensions. The company also provides product support through associate manufacturing plants for APIs, pellets, excipients, enzymes, and specialized chemicals, operating in compliance with cGMP, WHO-GMP, and EU-GMP standards. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Zeon Pharma Industries India Pvt Ltd

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTogether we can improve the quality of life

Flag India
Digital Content Digital Content

Olopatadine Hydrochloride

About the Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities...

Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities and partners with 16+ plants. Holding USFDA, EU-GMP, WHO-GMP, and other certifications, it is the largest exporter for 12 molecules worldwide. With robust regulatory compliance (DMF, CEP, ICH Q7), Shamrock is the preferred API partner in India. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

09

Biotechnica DWC

Algeria
AOCS Annual Meeting
Not Confirmed
arrow

Biotechnica DWC

Algeria
arrow
AOCS Annual Meeting
Not Confirmed

olopatadine hydrochloride

About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...

BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies all over the world. Biotechnica is an integrated global solution provider from design to implementation of industrial projects in the areas of Pharmaceuticals,Agri-food ,Cosmetics and Nutrition. With more than 25 years of experience in the assembly of plants, particularly in the pharmaceutical sector, we accompany our customers in the various stages of their projects – E-CTD Dossieers – Raw Materiels – Equipements – Accessories – Packaging – Distribution.
blank

10

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

OLOPATADINE HCl

About the Company : Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates ...

Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates and APIs. It has passed ISO9001:2000 international quality management system certificate. Its business scope includes development and manufacturing of APIs and pharmaceutical intermediates, contract development and manufacturing for domestic and international pharmaceutical companies, technical consultation, service and transfer.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Olopatadine HCl, a miscellaneous product targeting the Histamine H1 receptor, shows promise in relieving itchy eyes.


Lead Product(s): Olopatadine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Pataday-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 14, 2026

Dr Reddy Company Banner

01

Lead Product(s) : Olopatadine Hydrochloride,Inapplicable

Therapeutic Area : Ophthalmology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Olopatadine HCl, a miscellaneous product targeting the Histamine H1 receptor, shows promise in relieving itchy eyes.

Product Name : Pataday-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 14, 2026

Dr Reddy Company Banner

Details:

Dr. Reddy’s has launched of over-the-counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the storebrand equivalents of Pataday® Once Daily Relief and Pataday® Twice Daily Relief, in the U.S. market, as approved by the USFDA.


Lead Product(s): Olopatadine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Pataday-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 17, 2020

Dr Reddy Company Banner

02

Lead Product(s) : Olopatadine Hydrochloride,Inapplicable

Therapeutic Area : Ophthalmology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Dr. Reddy’s has launched of over-the-counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the storebrand equivalents of Pataday® Once Daily Relief and Pataday® Twice Daily Relief, in the U.S. market, as approved by the USFDA.

Product Name : Pataday-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 17, 2020

Dr Reddy Company Banner

Details:

Olopatadine HCl, a histamine H1 receptor antagonist, shows promise in treating allergic rhinitis.


Lead Product(s): Olopatadine Hydrochloride,Mometasone Furoate

Therapeutic Area: Immunology Brand Name: Ryaltris

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 11, 2025

blank

03

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : Olopatadine HCl, a histamine H1 receptor antagonist, shows promise in treating allergic rhinitis.

Product Name : Ryaltris

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 11, 2025

blank

Details:

Olopatadine HCl, a miscellaneous product targeting the Histamine H1 receptor, shows promising results in treating Allergic Rhinitis.


Lead Product(s): Olopatadine Hydrochloride,Mometasone Furoate

Therapeutic Area: Immunology Brand Name: Ryaltris

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 11, 2025

blank

04

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : Olopatadine HCl, a miscellaneous product targeting the Histamine H1 receptor, shows promising results in treating Allergic Rhinitis.

Product Name : Ryaltris

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 11, 2025

blank

Details:

Olopatadine HCl is a mast cell stabilizer and a histamine H1 antagonist. It is indicated for the treatment of ocular itching associated with allergic conjunctivitis.


Lead Product(s): Olopatadine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Pataday-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 16, 2025

blank

05

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : Olopatadine HCl is a mast cell stabilizer and a histamine H1 antagonist. It is indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Product Name : Pataday-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 16, 2025

blank

Details:

Pataday-Generic (olopatadine hydrochloride) solution is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis


Lead Product(s): Olopatadine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Pataday-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 20, 2025

blank

06

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : Pataday-Generic (olopatadine hydrochloride) solution is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis

Product Name : Pataday-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 20, 2025

blank

Details:

Olopatadine HCl solution is a mast cell stabilizer, works by H1R antagonist, indicated for the treatment of ocular itching associated with allergic conjunctivitis.


Lead Product(s): Olopatadine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Pataday-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 04, 2024

blank

07

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : Olopatadine HCl solution is a mast cell stabilizer, works by H1R antagonist, indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Product Name : Pataday-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 04, 2024

blank

Details:

Pataday-Generic (olopatadine hydrochloride) is a solution that is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis.


Lead Product(s): Olopatadine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Pataday-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 19, 2024

blank

08

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : Pataday-Generic (olopatadine hydrochloride) is a solution that is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Product Name : Pataday-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 19, 2024

blank

Details:

Azelastine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Rhinitis, Allergic, Seasonal.


Lead Product(s): Azelastine Hydrochloride,Mometasone Furoate,Olopatadine Hydrochloride

Therapeutic Area: Immunology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 13, 2023

blank

09

Viatris

U.S.A
arrow
Arvo
Not Confirmed

Viatris

U.S.A
arrow
Arvo
Not Confirmed

Details : Azelastine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Rhinitis, Allergic, Seasonal.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 13, 2023

blank

Details:

RYALTRIS® (olopatadine hydrochloride and mometasone furoate nasal spray) treats moderate to severe seasonal allergic rhinitis (SAR) and associated ocular symptoms in adults, adolescents, and children aged 6 years and older.


Lead Product(s): Olopatadine Hydrochloride,Mometasone Furoate

Therapeutic Area: Immunology Brand Name: Ryaltris

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Glenmark Pharmaceuticals

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 23, 2022

blank

10

Bausch Health

Canada
arrow
Arvo
Not Confirmed

Bausch Health

Canada
arrow
Arvo
Not Confirmed

Details : RYALTRIS® (olopatadine hydrochloride and mometasone furoate nasal spray) treats moderate to severe seasonal allergic rhinitis (SAR) and associated ocular symptoms in adults, adolescents, and children aged 6 years and older.

Product Name : Ryaltris

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 23, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

CAS Number : 27710-82-3

End Use API : Olopatadine Hydrochloride

About The Company : Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian manufacturer of APIs and intermediates. The company is approved by the FDA of India and holds cGMP ...

Bhavna Labs

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

CAS Number : 55453-87-7

End Use API : Olopatadine Hydrochloride

About The Company : Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian manufacturer of APIs and intermediates. The company is approved by the FDA of India and holds cGMP ...

Bhavna Labs

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

CAS Number : 2971-79-1

End Use API : Olopatadine Hydrochloride

About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...

Tagoor Laboratories

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIndian Drugs & Chemicals – delivering trusted APIs, intermediates & fine chemicals worldwide with 40+ years of quality expertise.

CAS Number : 3934-20-1

End Use API : Olopatadine Hydrochloride

About The Company : Indian Drugs And Chemicals supplies quality products using modern technologies, supported by strong industry expertise. The company serves global markets with a...

Company Banner

05

AOCS Annual Meeting
Not Confirmed
arrow
AOCS Annual Meeting
Not Confirmed
arrow

CAS Number : 27710-82-3

End Use API : Olopatadine Hydrochloride

About The Company : Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceu...

blank

06

AOCS Annual Meeting
Not Confirmed
arrow
AOCS Annual Meeting
Not Confirmed
arrow

CAS Number : CAS-55453-89-9

End Use API : Olopatadine Hydrochloride

About The Company : Jinan Lead Pharmaceutical Technology Co., LTD., located in Jinan, Shandong Province, is mainly engaged in R&D, production and sales of pharmaceutical raw materi...

blank

07

AOCS Annual Meeting
Not Confirmed
arrow
AOCS Annual Meeting
Not Confirmed
arrow

CAS Number : CAS-55453-87-7

End Use API : Olopatadine Hydrochloride

About The Company : Jinan Lead Pharmaceutical Technology Co., LTD., located in Jinan, Shandong Province, is mainly engaged in R&D, production and sales of pharmaceutical raw materi...

blank

08

AOCS Annual Meeting
Not Confirmed
arrow
AOCS Annual Meeting
Not Confirmed
arrow

CAS Number : CAS-27710-82-3

End Use API : Olopatadine Hydrochloride

About The Company : Jinan Lead Pharmaceutical Technology Co., LTD., located in Jinan, Shandong Province, is mainly engaged in R&D, production and sales of pharmaceutical raw materi...

blank

09

AOCS Annual Meeting
Not Confirmed
arrow
AOCS Annual Meeting
Not Confirmed
arrow

CAS Number : 55453-87-7

End Use API : Olopatadine Hydrochloride

About The Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory ...

blank

10

AOCS Annual Meeting
Not Confirmed
arrow
AOCS Annual Meeting
Not Confirmed
arrow

CAS Number : 55453-87-7

End Use API : Olopatadine Hydrochloride

About The Company : Progress is a company led by professionals, established by technocrats with a vision for global business expansion. Our headquarters are located in Vashi, Mumba...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% ...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE

USFDA APPLICATION NUMBER - 206276

read-more

DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% ...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE

USFDA APPLICATION NUMBER - 20688

read-more

DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% ...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE

USFDA APPLICATION NUMBER - 21545

read-more

DOSAGE - SPRAY, METERED;NASAL - 0.665MG/SPRAY...DOSAGE - SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21861

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

Parenteral

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Solubilizers

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Empty Capsules

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Topical

read-more
read-more

Rheology Modifiers

read-more
read-more

Emulsifying Agents

read-more
read-more

Lubricants & Glidants

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

Analytical Methods

read-more
read-more

ABOUT THIS PAGE

Looking for 140462-76-6 / Olopatadine Hydrochloride API manufacturers, exporters & distributors?

Olopatadine Hydrochloride manufacturers, exporters & distributors 1

91

PharmaCompass offers a list of Olopatadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Olopatadine Hydrochloride manufacturer or Olopatadine Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Olopatadine Hydrochloride manufacturer or Olopatadine Hydrochloride supplier.

API | Excipient name

Olopatadine Hydrochloride

Synonyms

140462-76-6, Olopatadine hcl, Allelock, Pataday, Patanase, Alo4943a

Cas Number

140462-76-6

Unique Ingredient Identifier (UNII)

2XG66W44KF

About Olopatadine Hydrochloride

An antihistamine with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.

Opatanol Manufacturers

A Opatanol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Opatanol, including repackagers and relabelers. The FDA regulates Opatanol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Opatanol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Opatanol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Opatanol Suppliers

A Opatanol supplier is an individual or a company that provides Opatanol active pharmaceutical ingredient (API) or Opatanol finished formulations upon request. The Opatanol suppliers may include Opatanol API manufacturers, exporters, distributors and traders.

click here to find a list of Opatanol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Opatanol USDMF

A Opatanol DMF (Drug Master File) is a document detailing the whole manufacturing process of Opatanol active pharmaceutical ingredient (API) in detail. Different forms of Opatanol DMFs exist exist since differing nations have different regulations, such as Opatanol USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Opatanol DMF submitted to regulatory agencies in the US is known as a USDMF. Opatanol USDMF includes data on Opatanol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Opatanol USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Opatanol suppliers with USDMF on PharmaCompass.

Opatanol JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Opatanol Drug Master File in Japan (Opatanol JDMF) empowers Opatanol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Opatanol JDMF during the approval evaluation for pharmaceutical products. At the time of Opatanol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Opatanol suppliers with JDMF on PharmaCompass.

Opatanol KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Opatanol Drug Master File in Korea (Opatanol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Opatanol. The MFDS reviews the Opatanol KDMF as part of the drug registration process and uses the information provided in the Opatanol KDMF to evaluate the safety and efficacy of the drug.

After submitting a Opatanol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Opatanol API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Opatanol suppliers with KDMF on PharmaCompass.

Opatanol WC

A Opatanol written confirmation (Opatanol WC) is an official document issued by a regulatory agency to a Opatanol manufacturer, verifying that the manufacturing facility of a Opatanol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Opatanol APIs or Opatanol finished pharmaceutical products to another nation, regulatory agencies frequently require a Opatanol WC (written confirmation) as part of the regulatory process.

click here to find a list of Opatanol suppliers with Written Confirmation (WC) on PharmaCompass.

Opatanol NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Opatanol as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Opatanol API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Opatanol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Opatanol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Opatanol NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Opatanol suppliers with NDC on PharmaCompass.

Opatanol GMP

Opatanol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Opatanol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Opatanol GMP manufacturer or Opatanol GMP API supplier for your needs.

Opatanol CoA

A Opatanol CoA (Certificate of Analysis) is a formal document that attests to Opatanol's compliance with Opatanol specifications and serves as a tool for batch-level quality control.

Opatanol CoA mostly includes findings from lab analyses of a specific batch. For each Opatanol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Opatanol may be tested according to a variety of international standards, such as European Pharmacopoeia (Opatanol EP), Opatanol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Opatanol USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty